Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

SELL
$49.7 - $57.71 $111,825 - $129,847
-2,250 Reduced 30.73%
5,072 $0
Q3 2022

Nov 10, 2022

SELL
$53.86 - $66.8 $27,953 - $34,669
-519 Reduced 6.62%
7,322 $398,000
Q2 2022

Jul 19, 2022

SELL
$63.83 - $80.0 $72,447 - $90,800
-1,135 Reduced 12.64%
7,841 $504,000
Q1 2022

May 19, 2022

SELL
$76.85 - $89.45 $46,110 - $53,670
-600 Reduced 6.27%
8,976 $696,000
Q4 2021

Feb 03, 2022

SELL
$74.57 - $87.19 $4.96 Million - $5.8 Million
-66,549 Reduced 87.42%
9,576 $813,000
Q4 2021

Feb 02, 2022

BUY
$74.57 - $87.19 $4.98 Million - $5.83 Million
66,809 Added 717.14%
76,125 $7.84 Million
Q3 2021

Oct 14, 2021

SELL
$73.77 - $83.61 $17,704 - $20,066
-240 Reduced 2.51%
9,316 $753,000
Q2 2021

Jul 29, 2021

SELL
$80.5 - $88.01 $32,200 - $35,204
-400 Reduced 4.02%
9,556 $769,000
Q4 2020

Feb 02, 2021

SELL
$75.39 - $82.36 $18,847 - $20,590
-250 Reduced 2.45%
9,956 $799,000
Q3 2020

Oct 23, 2020

SELL
$78.33 - $90.73 $46,528 - $53,893
-594 Reduced 5.5%
10,206 $801,000
Q2 2020

Jul 17, 2020

SELL
$78.66 - $94.14 $29,497 - $35,302
-375 Reduced 3.36%
10,800 $920,000
Q1 2020

Apr 30, 2020

SELL
$71.57 - $93.3 $45,089 - $58,779
-630 Reduced 5.34%
11,175 $1.04 Million
Q4 2019

Feb 13, 2020

SELL
$76.7 - $88.45 $23,010 - $26,535
-300 Reduced 2.48%
11,805 $987,000
Q2 2019

Jul 30, 2019

BUY
$73.44 - $82.41 $852,271 - $956,368
11,605 Added 2321.0%
12,105 $991,000
Q3 2018

Oct 22, 2018

BUY
$70.71 - $77.75 $35,355 - $38,875
500 New
500 $38,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Wespac Advisors So Cal, LLC Portfolio

Follow Wespac Advisors So Cal, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.